I am ready for a long road flight for work with a week- or months-long projects.
Any question about our company, a partnership, or job opportunities?
Please complete our contact form and we will get in touch ASAP
By clicking submit below, you consent to allow Gero to store and process the personal information submitted above to provide you the content requested.
Our collaborators
Get GERO.AI presentation
Please notice, we will consider providing you with a presentation only If you use your full name and corporate e-mail.
By clicking submit below, you consent to allow Gero to store and process the personal information submitted above to provide you the content requested.
Get GERO.AI presentation
Please notice, we will consider providing you with a presentation only If you use your full name and corporate e-mail.
By clicking submit below, you consent to allow Gero to store and process the personal information submitted above to provide you the content requested.
We Invite You to Discover Revolutionary Drugs Together
We are pioneers in AI for Drug Discovery and Aging Research fields, but we lack deep expertise in every indication. This is why we value collaboration.
If you are a Pharma or a Biotech looking for new targets with novel MoAs, do not hesitate to contact us.
If you are a Pharma or a Biotech looking for new targets with novel MoAs, do not hesitate to contact us.
Gero.ai
Any question about our company, a partnership, or job opportunities?
Please complete our contact form and we will get in touch ASAP
By clicking submit below, you consent to allow Gero to store and process the personal information submitted above to provide you the content requested.
Utilizing whole-exome sequencing data for in-human AI drug discovery
GERO.AI identifies rare mutations sufficiently affecting health from real-world big clinical and genetic (WES) and molecular data and then suggests druggable targets and drugs (mimicking or inhibiting) the effect of mutation to treat the disease.
We are able to aggregate the effects of multiple rare mutations on the level of biological processes and pathways and give you multiple choices of interventions with the required effect.
We are able to aggregate the effects of multiple rare mutations on the level of biological processes and pathways and give you multiple choices of interventions with the required effect.
Our Approach
Hacking aging
Aging is a natural part and the "last mile" of a human development program, and Gero pioneer ways to understand, measure, and, ultimately, control its progression.
Mission
Longevity Biotech Gero Entered a Research Collaboration with Pfizer to Discover Potential Targets for Fibrotic Diseases
— "We are excited to work with Pfizer, one of the world’s leading biopharmaceutical companies, to potentially identify targets against fibrotic diseases, which have a large unmet need. We believe that combining our platform technology with Pfizer’s extensive disease expertise has the potential to identify high-value targets in this disease area."
Alex Kadet, CBO of Gero.
Alex Kadet, CBO of Gero.
Collaborations
Gero in media